{
  "citations" : [],
  "guideline" : {
    "objCls" : "Guideline Annotation",
    "id" : "PA166288581",
    "name" : "Annotation of CPIC Guideline for citalopram, escitalopram and HTR2A",
    "alternateDrugAvailable" : false,
    "cancerGenome" : false,
    "crossReferences" : [],
    "descriptiveVideoId" : "UWRTwdNT1ek",
    "dosingInformation" : false,
    "hasTestingInfo" : false,
    "history" : [
      {
        "id" : 1452065061,
        "date" : "2023-04-10T14:28:40.263-07:00",
        "description" : "added CPIC guideline publication",
        "type" : "Update",
        "version" : 0
      },
      {
        "id" : 1452553460,
        "date" : "2024-08-12T04:53:04.005-07:00",
        "description" : "Added video",
        "type" : "Update",
        "version" : 0
      }
    ],
    "literature" : [
      {"id":15143242,"title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.","_sameAs":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564324","crossReferences":[{"id":1452680439,"resource":"PubMed Central","resourceId":"PMC10564324","_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564324"},{"id":1452064840,"resource":"PubMed","resourceId":"37032427","_url":"https://www.ncbi.nlm.nih.gov/pubmed/37032427"},{"id":1452064841,"resource":"DOI","resourceId":"10.1002/cpt.2903","_url":"http://dx.doi.org/10.1002%2Fcpt.2903"}],"objCls":"Literature","pubDate":"2023-07-01T00:00:00-07:00","terms":[{"id":1451577480,"resource":"PGx Paper Types","term":"Implementation","termId":"pgxPaperTypes:1451577480"}],"type":"Literature"}
    ],
    "otherPrescribingGuidance" : false,
    "pediatric" : false,
    "recommendation" : false,
    "relatedAlleles" : [],
    "relatedChemicals" : [
      {
        "objCls" : "Chemical",
        "id" : "PA449015",
        "name" : "citalopram",
        "version" : 21
      },
      {
        "objCls" : "Chemical",
        "id" : "PA10074",
        "name" : "escitalopram",
        "version" : 11
      }
    ],
    "relatedGenes" : [
      {
        "objCls" : "Gene",
        "id" : "PA193",
        "symbol" : "HTR2A",
        "name" : "5-hydroxytryptamine receptor 2A",
        "version" : 145
      }
    ],
    "source" : "CPIC",
    "summaryMarkdown" : {
      "id" : 1452007460,
      "html" : "<p>There are currently no recommendations for dosing of escitalopram and citalopram based on <em>HTR2A</em> genotypes.</p>\n",
      "version" : 0
    },
    "terms" : [],
    "textMarkdown" : {
      "id" : 1452007461,
      "html" : "<p>This annotation is based on the <a rel=\"noopener noreferrer\" href=\"https://cpicpgx.org/guidelines/cpic-guideline-for-ssri-and-snri-antidepressants/\" target=\"_blank\">CPIC&reg; guideline for <em>CYP2D6</em>, <em>CYP2C19</em>, <em>CYP2B6</em>, <em>SLC6A4</em>, and <em>HTR2A</em> Genotypes and Serotonin Reuptake Inhibitor Antidepressants</a>.</p>\n<h3 id=\"february-2023\">February 2023</h3>\n<p>The authors of the <a rel=\"noopener noreferrer\" href=\"https://cpicpgx.org/guidelines/cpic-guideline-for-ssri-and-snri-antidepressants/\" target=\"_blank\">CPIC&reg; guideline for <em>CYP2D6</em>, <em>CYP2C19</em>, <em>CYP2B6</em>, <em>SLC6A4</em>, and <em>HTR2A</em> Genotypes and Serotonin Reuptake Inhibitor Antidepressants</a> evaluated the available evidence for the use of es-/citalopram in patients carrying <em>HTR2A</em> variants.</p>\n<ul>\n<li>\n<p>Excerpts from the guideline:</p>\n<ul>\n<li>&quot;Clinical recommendations are not provided for serotonin reuptake inhibitor antidepressants based on <em>HTR2A</em> and <em>SLC6A4</em> genotypes because the evidence supporting an association is mixed and/or insufficient to support clinical validity and utility at this time (CPIC level C-no recommendation).&quot;</li>\n</ul>\n</li>\n<li>\n<p>Download and read:</p>\n<ul>\n<li><a rel=\"noopener noreferrer\" href=\"https://files.cpicpgx.org/data/guideline/publication/serotonin_reuptake_inhibitor_antidepressants/2023/37032427.pdf\" target=\"_blank\">CPIC&reg; Guideline for for <em>CYP2D6</em>, <em>CYP2C19</em>, <em>CYP2B6</em>, <em>SLC6A4</em>, and <em>HTR2A</em> Genotypes and Serotonin Reuptake Inhibitor Antidepressants</a></li>\n<li><a rel=\"noopener noreferrer\" href=\"https://files.cpicpgx.org/data/guideline/publication/serotonin_reuptake_inhibitor_antidepressants/2023/37032427-supplement.pdf\" target=\"_blank\">2023 supplement</a></li>\n</ul>\n</li>\n</ul>\n<h3 id=\"table-1-dosing-recommendations-for-es-citalopram-based-on-htr2a-genotype\">Table 1: Dosing recommendations for es-/citalopram based on <em>HTR2A</em> genotype</h3>\n<p><em>Adapted from Table S7 of the guideline supplement.</em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Genotype</th>\n<th>Implications</th>\n<th>Recommendations</th>\n<th>Classification of recommendation</th>\n<th>Considerations</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>rs6311G; rs6313C</td>\n<td>Mixed evidence for the effect of genetic variability on citalopram/escitalopram response, remission or side effects.</td>\n<td>No action recommended based on genotype for citalopram/escitalopram because of insufficient evidence supporting clinical use.</td>\n<td>No recommendation</td>\n<td>Some meta-analyses show a small but statistically significant antidepressant class association with response, remission or side effects but there remains a lack of clarity regarding how to translate this into clinical action.</td>\n</tr>\n<tr>\n<td>rs7997012G</td>\n<td>Mixed evidence for the effect of genetic variability on citalopram/escitalopram response or remission.</td>\n<td>No action recommended based on genotype for citalopram/escitalopram because of insufficient evidence supporting clinical use.</td>\n<td>No recommendation</td>\n<td>Some meta-analyses show a statistically significant small to medium antidepressant class association with response or remission but there remains a lack of clarity regarding how to translate this into clinical action.</td>\n</tr>\n<tr>\n<td>Other variants</td>\n<td>No effect or insufficient evidence for escitalopram/citalopram response, remission or side effects.</td>\n<td>No action recommended based on genotype for citalopram/escitalopram because of insufficient evidence supporting clinical use.</td>\n<td>No recommendation</td>\n<td></td>\n</tr>\n</tbody>\n</table>\n",
      "version" : 0
    },
    "version" : 1
  }
}